Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNASALStandard

KLOXXADO

NALOXONE HYDROCHLORIDE

Standard Dose
4MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview KLOXXADO is listed in Drugs@FDA under application 212045 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NALOXONE HYDROCHLORIDE Form and strength SPRAY;NASAL - 4MG/SPRAY Sponsor HIKMA Submission history Latest submission status date: 2025-08-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview KLOXXADO is listed in Drugs@FDA under application 212045 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NALOXONE HYDROCHLORIDE Form and strength SPRAY;NASAL - 4MG/SPRAY Sponsor HIKMA Submission history Latest submission status date: 2025-08-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.